2201 Peri-operative chemotherapy ± bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948)
David Cunningham(Royal Marsden NHS Foundation Trust), R. Langley, Sue Chua, S Rowley, Sally Stenning(Medical Research Council), Derek Alderson(University of Bristol), S M Griffin(Royal Victoria Infirmary), Jane Blazeby(Royal College of Surgeons of England), Tom Crosby(Southampton General Hospital), W. Mansoor, Anna Riddell, Leanne Stevenson(Queen's University Belfast), RC Mason, S. Falk, E. Smyth, W H Allum, C. Robb, Fareeda Y. Coxon(Newcastle upon Tyne Hospitals NHS Foundation Trust), Kate Sumpter(Freeman Hospital), Heike I. Grabsch(University of Leeds)
Cited by 31
Related Papers
Gastric cancer
|The Lancet|2020|4.8k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k